Cellectis Financials
| CMVLF Stock | USD 2.54 0.00 0.00% |
Cellectis |
Understanding current and past Cellectis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cellectis' financial statements are interrelated, with each one affecting the others. For example, an increase in Cellectis' assets may result in an increase in income on the income statement.
Cellectis Stock Summary
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. Cellectis Romainvil operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 294 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 8, rue de |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.cellectis.com |
| Phone | 33 1 81 69 16 00 |
| Currency | USD - US Dollar |
Cellectis Key Financial Ratios
There are many critical financial ratios that Cellectis' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cellectis SA reports annually and quarterly.Cellectis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cellectis's current stock value. Our valuation model uses many indicators to compare Cellectis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cellectis competition to find correlations between indicators driving Cellectis's intrinsic value. More Info.Cellectis SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cellectis' earnings, one of the primary drivers of an investment's value.Cellectis SA Systematic Risk
Cellectis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cellectis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Cellectis SA correlated with the market. If Beta is less than 0 Cellectis generally moves in the opposite direction as compared to the market. If Cellectis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cellectis SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cellectis is generally in the same direction as the market. If Beta > 1 Cellectis moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Cellectis Pink Sheet analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |